Bill > AB1682

This bill mandates that health care service plans and health insurance policies, starting January 1, 2027, must cover scalp cooling treatments when prescribed by a healthcare provider in connection with chemotherapy for cancer patients, with the goal of reducing hair loss. Scalp cooling is defined as the use of a medical device or system cleared by the U.S. Food and Drug Administration (FDA) applied to the scalp during chemotherapy. This coverage requirement applies to both private insurance and the state's Medi-Cal program, provided federal funding is available and not jeopardized. The bill also specifies that any copayments, coinsurance, or deductibles for scalp cooling must be no less favorable to patients than those for other oncology supportive care services.